Augmented demand for patient-centric models has been shaping the ablation devices market for many years.Moreover, aggressive shift towards minimal invasion, reduced hospitalization rate, greater clinical efficacy, and lower cost is supporting the market growth.Therefore, FMI projects the net revenue pool to exceed US$ 8 Bn by 2029 end.“Highly sought-after attributes such as proven procedural efficacy, enhanced safety profiles, and greater awareness are fueling the demand for ablation devices in asymptomatic procedure-related events.Hence, the global ablation devices market will witness stellar growth at approximately 11% CAGR over the forecast period (2019-2029),” says the FMI analyst.Request report sample with 300 pages to gain in-depth insights https://www.futuremarketinsights.com/reports/sample/rep-gb-11254Key Takeaways of Ablation Devices Market StudyAdvanced ablation catheters will continue to stay atop, accounting for 68% revenue in terms of product type.Radiofrequency technology remains highly preferred by manufacturers across the globe.In terms of function, conventional ablation devices will capture leading value proportion over the forecast period.Clinics and hospitals are prominent end users on account of trained medical staff and greater availability of ablation devices.Europe and North America collectively hold 70% share in the overall market stack.Ablation Devices Market – Key Growth FactorsRising adoption of automated robotic ablation devices is stimulating the market growth.Rapid investments by governments in developed countries towards healthcare infrastructure are complementing the growth of ablation devices market.Advancements in state-of-the-art medical equipment will support the market growth over the projection period.Lesser recovery time and lesser potential risks of radiofrequency technology are boosting its wider adoption.Popularity of cryoablation catheters in treating arrhythmias will support the growth of this segment through 2029.Rising life expectancy combined with growing geriatric population are significant revenue contributors of global ablation devices market.Ablation Devices Market – Key RestraintsPotential damage caused by the use ablation devices at the cellular level is limiting the growth of market.The medical fraternity is giving preference to treat COVID-19 patients while other elective procedures are being postponed worldwide.Addressing the economic concerns remains the top priority of niche players in the global ablation devices market.Explore the full ablation devices market report with 238 illustrative figures, 78 data tables and table of contents.
According to the FMI report, the global clinical trials market was valued over US$ 90 Bn in 2019 and is projected to expand at a CAGR of ~4% from 2019 to 2029.Medical device and pharma giants are already eyeing better approaches for clinical trials, implementing a combination of their current systems and better technologies to ebb challenges in critical areas – orphan drugs and rare diseases.The ubiquity digital technologies is evidently growing, as these (including but not limited to ingestible devices, sensors, and wearable health monitors) hold the potential to disrupt the aspects of clinical trials.Download the Sample copy of Report with Table of Contents and Figures @ https://www.futuremarketinsights.com/reports/sample/rep-gb-384According to the study, the clinical trials landscape is witnessing a paradigm shift toward patient centricity, in a bid to incorporate perspective of patients during the clinical trial design.Key enterprises are adopting unconventional approaches by implementing site-centric method, using operational support systems and technology for bringing studies to the trial-naïve physicians.Industry Sponsors Account for Majority Clinical Trial SpendingThe most remarkable advances in medicine are realized from sponsorships of companies for clinical trials, in the anticipation of turning a profit.Recent studies state that industry-sponsored trials yield positive results compared to academic-run trials, which also account for a significant share of clinical trial spending.Preview analysis of Clinical Trials Market is segmented by (Area – Oncology, Infectious Disease, Metabolic Disorders, Cardiovascular, Neuroscience, Respiratory & Others; Phase – Phase 0,Phase I,Phase II, Phase III & Phase IV; Sponsor – Industry-sponsored, Government / Public, Non-governmental Organizations & Others (Academic Medical Centers, Individuals, etc.);) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 – 2029: https://www.futuremarketinsights.com/reports/clinical-trials-marketAccording to FMI, sponsors, such as academic institutes, research institutes and medical centers, are estimated to account for ~30% clinical trial spending in 2019.
Future Market Insights (FMI) delivers key insights on the global spinal fusion market in its upcoming report titled "Spinal Fusion Market: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017 - 2027."In terms of revenue, the global spinal fusion market is projected to register a CAGR of 5.4% over the forecast period, owing to various factors, regarding which FMI offers detailed insights and forecasts in this report.A key trend witnessed in the global spinal fusion market is the rise in the development of minimising load due to increasing adverse reactions.Furthermore, the growing importance of developing advanced products among big players to enhance their product portfolio is another key trend in the global spinal fusion market.Spinal fusion is a surgical procedure to fuse two or more vertebrae to restrict their movement.The procedure is recommended to eliminate the pain caused by incorrect movement of vertebrae.Although the procedure is most commonly done for lumbar region, cervical and thoracic vertebrae can also be treated in cases of damage due to accidents or to reduce pressure on the nerves.Download a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-5259Market Segmentation and ForecastThe global spinal fusion market is segmented based on product type, procedure type, end user and region.Attenuated interbody cages segment will represent major revenue share of the global spinal fusion market in 2017.By procedure, the global spinal fusion market is segmented into posterolateral fusion and interbody fusion.
A latest research study published by Future Market Insights (FMI) projects the global competent cells market to register an impressive 8.1% CAGR throughout the forecast period 2017 to 2022.Competent Cells Available in the Market in Ready-to-use FormatsPreparations of competent cells, along with other methods of transformation, have been continuously improvised, since the development of E. coli’s artificial transformation with the help of electroporation and chemicals.Currently, various competent cells are available in the market in ready-to-use formats for propagating cloned plasmids in the experiments of molecular biology.Over the past few years, the recombinant proteins and molecular cloned products have experienced a robust commercial demand, thereby driving adoption of competent cells.However, adoption of competent cells is witnessing strong barriers on the back of increasing consolidation of the market, and huge cost of kits related to competent cells.North America will Continue to be Largest Market for Competent CellsIn terms of revenues, North America is anticipated to remain the largest market for competent cells, with sales estimated to exceed US$ 750 Mn in revenues by 2022-end.Growing demand for electrocompetent cells can be mainly attributed to their provision of high transformation efficiencies, making them suitable for several molecular biology applications, for example – construction of gene banks, or, generation of cDNA libraries.
According to the latest research by the company, the global frontotemporal disorders treatment market is expected to be valued at US$ 451.4 Mn, by 2028 end.Government organizations such as the National Institute of Aging (NIA), National Institute of Neurological Disorders and Strokes (NINDS) and National Institute of Health (NIH) are conducting research and development support programs and making efforts to advance therapeutic development in neurological diseases.Research funding initiatives by non-profit organization such as the Association for Frontotemporal Degeneration (AFTD), Alzheimer Discovery Foundation (ADDF), Bluefield Project Organization, Tau Consortium Organization, CurePSP, Inc. have helped to promote FTD research initiatives.Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-5033However, lack of approved drugs for frontotemporal disorder treatment is expected to negatively impact the growth of the frontotemporal disorders treatment market.Moreover, the high failure rate of clinical trials and studies is also a major factor expected to hamper the growth of the frontotemporal disorders treatment market.The company has segmented the global frontotemporal disorders treatment market based on drug class, treatment type, disease indication, distribution channel, and regions.Based on drug class, the frontotemporal disorders treatment market is segmented into cognitive enhancers, antipsychotics, antidepressants, CNS stimulants, and others.In terms of revenue, the frontotemporal dementia segment is projected to hold significant share in the global frontotemporal disorders treatment market over the forecast period.
It is powered by either electric motor or air turbines.A new research report by FMI titled ‘Electric Dental Handpiece Market: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017–2027’ gives clear insights on the market and its various segments.The market is anticipated to grow at a CAGR OF 5.2% during the forecast period.The market growth will make many companies focus solely on providing dental handpieces.Tie-ups with distributors and other channel partners ensure continuous product availability and will help in expanding product reach both geographically and in non-traditional end use settings.View Report Preview at Electric Dental Handpiece Market Segmentation By Motor Type - Brush Motor, Brushless Motor; By End User – Hospitals, Dental Clinics, Others: https://www.futuremarketinsights.com/reports/electric-dental-handpiece-market Electric Dental Handpiece Market: DynamicsThe growth of the global electric dental handpiece market is helped by a lot of factors.The increase in dental disorders also plays a crucial role in augmenting market revenue.People have started using more artificial products and there is a visible increase in the carelessness towards teeth, which has increased the rate of dental disorders.
Increasing adoption of phototherapy as a safer option for treatment of skin disorders has propelled the sales of phototherapy lamps across the globe.According to a recent research report by FMI, the global phototherapy lamps market is anticipated to expand robustly at a CAGR of 6.8% during the forecast period.The healthcare marketplace in the US and Canada has shown considerable rise in adoption of phototherapy as a safer treatment option for skin disorders.In addition, robust infrastructure for adoption of phototherapy lamps has also supported the dominance of North America in the global market.The report reveals that in 2017, phototherapy lamps sold in the US and Canada will bring in nearly US$ 700 Mn in revenues.View Report Preview at Phototherapy Lamps Market segmentation by Product Type- LED, UV LIGHT, Halogen Lamps; End User- Hospital, Skin care clinics, Home care Setting, Other End Users; Application- Psoriasis, Vitiligo, Acne, Neonatal Jaundice, Other Application https://www.futuremarketinsights.com/reports/phototherapy-lamps-marketLED-based phototherapy lamps to register highest salesThe study reveals that LED-based phototherapy lamps are the top-selling products in the global market.Low risk of burns, cost-effective production, and easy installation will continue to drive the demand for LED-based phototherapy lamps in the foreseeable future.
The global prosthetic heart valve market was valued at US$ 5,650 Mn in 2015 and is estimated to be valued at US$ 6,304 Mn by 2016, projecting a Y-o-Y growth of 11.6%.Regulatory approval for heart valves, integration of technological advancements, and increasing number of heart valve implantation procedures are other factors expected to influence revenue growth of the global prosthetic heart valve market in the next 10 years.However, high costs associated with transcatheter heart valve products, procedure related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.Request a Sample Report with Table of Contents and Figures: http://www.futuremarketinsights.com/reports/sample/rep-gb-666Segmentation highlightsThe global prosthetic heart valve market is segmented on the basis of Product Type (Mechanical Heart Valves, Biological/Tissue Heart Valves, Transcatheter Heart Valves) and End User (Hospitals, Ambulatory Surgery Centres).The Transcatheter Heart Valves product type segment is estimated to be valued at US$ 6,069.1 Mn by 2026 end, registering a CAGR of 13.3% between 2016 and 2026.The Hospitals end user segment accounted for 74.5% market share of the global prosthetic heart valve market in 2015.Rising demand for quicker treatment options and remedies is expected to promote the revenue growth of the Hospitals segment over the forecast period.Preview Analysis on Global Prosthetic Heart Valve Market Segmentation By Product Type – Mechanical Heart Valves, Biological/Tissue Heart Valves, Transcatheter Heart Valves; By End User– Hospitals, Ambulatory Surgery Centres: http://www.futuremarketinsights.com/reports/prosthetic-heart-valve-marketRegional market projectionsThe global prosthetic heart valve market is segmented by region into North America, Latin America Excluding Brazil, Brazil, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Middle East & Africa (MEA).The global prosthetic heart valve market is largely prominent in the developed regions.The North America regional market is estimated to witness the highest CAGR of 12.4% during the forecast period followed by the Western Europe regional market at 12.1%.
A new research report by Future Market Insights revolves around examining the current scenario of global cellulite treatment market as well as forecast for its upcoming years.This comprehensive research report is titled ‘Cellulite Treatment Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028’.Hard Cellulite Predicted to Hold an Attractive Market Share in the Near FutureOne major driver behind the growth of cellulite treatment market is the increasing number of obese population.Especially in Brazil, where there were around 5,500 cosmetic surgeons performing the second highest number of aesthetic procedures after the U.S. Around 1,450,020 minimally invasive and non-surgical procedures were performed in Brazil in 2016.Among different types of cellulite, hard cellulite is expected to register a growth rate of around 7.8% during 2018-2028, which is higher than other cellulite types.Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-3560North America Slated for Strongest Projections in the Global Cellulite Treatment MarketAmong the major regional divisions made for the research conducted on global cellulite treatment market, North America shows the strongest prospects with an expected market value of over US$ 2,100 Mn by the end of 2028, growing at an impressive CAGR of 8.1% during the forecast period.The region is also ahead of other regions due to its developed economy and advanced facilities.This makes the market more prominent in developed regions like North America.Preview Cellulite Treatment Market Segmentation Treatment Procedure – Non-Invasive, Minimally Invasive, Topical Treatment; Cellulite – Soft Cellulite, Hard Cellulite, Edematous Cellulite; End User – Hospitals, Ambulatory Surgical Centers, Specialized Dermatology Clinics:https://www.futuremarketinsights.com/reports/cellulite-treatment-marketGlobal Cellulite Treatment Market: Competitive LandscapeThe research report has a detailed scenario of competition going on in the global cellulite treatment market.
The global veterinary lasers market is predicted to take a leap from US$ 123.2 Mn (2017) to a value worth US$ 336.5 Mn by the end of 2028.According to the latest market research report published on the global market for veterinary lasers by Future Market Insights, the global veterinary lasers market is projected to register a robust CAGR of 9.7% in terms of value during the forecast period 2018–2028.The report, titled “Veterinary Lasers Market - Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028” provides detailed analysis of the market over the next decade.Pet Ownership Prevails and Availability of Pet Healthcare WidensSignificant rise in the percentage of pet owners and increasing spending on pets by owners have been the key factors driving the demand for veterinary lasers over the years.Upgradation of veterinary hospitals and clinics that has been creating significant impact on the overall market scenario, coupled with an increasing number of healthcare facilities, will reportedly push the veterinary lasers market a little farther.Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-5410Pet Owners Continue to Look for Non-invasive Treatment Options Through Insurance CoverImproving implementation of pet insurance coverage is identified to act as a value-driver to market growth during the assessment period.The demand for non-invasive procedures is increasing among pet owners and a majority of them have already accepted laser therapies as a better, efficient, and less painful treatment alternative for pets.This factor will continue to play a crucial role in strengthening the market conditions in upcoming years.High Costs and Lack of Favorable Reimbursement Policies to Remain Longstanding ChallengesAlthough probable health risks and expensive costs associated with laser therapies may hamper the penetration of lasers worldwide, Future Market Insights estimates promising growth prospects for the market over 2018-2028.
Arthroscopy is a minimally invasive procedure for visualisation, diagnosis and treatment of joint problems.During arthroscopy procedure, surgeons inserts an arthroscope, which is a fibre-optic video camera, through a keyhole size incision.It allows arthroscopists to view inside the joint through a high-definition video monitor and determine the amount or type of injury, and further perform arthroscopy without the need of a large incision.An arthroscopy is used to treat a range of problems, such as damaged cartilage and fragments of loose bone or cartilage, as well as conditions such as arthritis and frozen shoulder or carpal tunnel syndrome.The Arthroscopy Procedures and Products market is segmented as follows:By Product TypeBy Procedure TypeBy RegionThis report covers the global arthroscopy procedures and products market performance in terms of revenue contribution.The report also includes FMI's analysis of key trends, drivers, restraints and opportunities that are influencing the global arthroscopy procedures and products market currently.Impact analysis of key growth drivers and restraints is included in this report to better equip clients with crystal-clear decision-making insights.Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1386By product type, the global arthroscopy procedures and products market is segmented into arthroscopes and visualization systems, arthroscopic resection systems, arthroscopic fluid management systems, arthroscopic implants, arthroscopy radiofrequency (RF) systems, arthroscopic drills and fixation systems and other arthroscopy instruments and accessories.The arthroscopic implants segment is further sub-segmented into knee implants, shoulder implants, hip implants and other implants.
Injecting HA lubricates bones to move smoothly over each other.Viscosupplementation facilitates movement and reduces pain in the arthritic joint.It is often recommended when other nonsurgical treatment methods have failed to provide positive outcomes.Future Market Insights (FMI) delivers key insights on the Europe viscosupplementation market in its upcoming report titled, “Viscosupplementation Market: Europe Industry Analysis and Opportunity Assessment, 2016-2026”.Based on product type, the market has been segmented into one injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation.Single injection viscosupplementation product type segment is expected to emerge as the most popular segment over the forecast period, driven by better patient compliance as the treatment reduces the need for multiple hospital visits.Reimbursement cutbacks and high injection costs are other factors that can curtail demand for five injection viscosupplementation.By end-users, the market is segmented into hospitals, ambulatory surgical centres and orthopaedic clinics.Better reimbursement options and increasing patient preference for single injection cycle for osteoarthritis treatment is expected to drive demand for one injection viscosupplementation in the orthopaedic clinics segment over the forecast period.Europe Viscosupplementation Market TrendsKey trends in the viscosupplementation market are the use of single injection cycle for osteoarthritis treatment and introduction of new combination products in the market.
The significant rise in lifestyle-related diseases and the developments in healthcare infrastructure are expected to influence the demand for pharmaceuticals in Saudi Arabia.Another key factor driving the growth of the pharmaceutical market in Saudi Arabia is the country's strategic move to allow 100% FDI in the pharmaceuticals sector.Although, the shortage of profound indigenous research capacity in the pharmaceutical industry and the delayed registration of drug and medicine patents is expected to limit the expansion of the market in 2016 and beyond.Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gc-1733Based on the product type, the pharmaceutical market in Saudi Arabia is expected to witness an upsurge in the prescription-type branded drug products.In terms of market value, the branded drugs are estimated to reach US$ 2,760.8 Mn by 2016-end.The demand for generic drugs is projected to secure steady growth, attributing to the insisting promotion of generic drug adoption by healthcare insurance providers.On the basis of the diseases, the pharmaceutical drugs used for treatment of cardiovascular diseases will continue exhibiting robust growth in 2016.Additionally, the rising prevalence of disorders related to body sugar levels is expected to make diabetes a rapidly growing disease-based sub-segment in the Saudi Arabia pharmaceutical market.The pharmaceutical market in Saudi Arabia is also segmented on the basis of distribution channel, where retail pharmacies will continue to account for 80% market share compared to hospital pharmacies.